Wiener Joshua, McIntyre Amanda, Janzen Shannon, Mirkowski Magdalena, MacKenzie Heather M, Teasell Robert
a Parkwood Institute Research , Lawson Health Research Institute,Parkwood Institute , London , Ontario , Canada.
b Parkwood Institute , St. Joseph's Health Care London , London , Ontario , Canada.
Brain Inj. 2019;33(5):559-566. doi: 10.1080/02699052.2019.1574328. Epub 2019 Jan 29.
Following traumatic brain injury (TBI), optimization of cerebral physiology is recommended to promote more favourable patient outcomes. Accompanying pain and agitation are commonly treated with sedative and analgesic agents, such as opioids. However, the impact of opioids on certain aspects of cerebral physiology is not well established.
To conduct a systematic review of the evidence on the effect of opioids on cerebral physiology in TBI during acute care.
A comprehensive literature search was conducted in five electronic databases for articles published in English up to November 2017. Studies were included if: (1) the study sample was human subjects with TBI; (2) the sample size was ≥3; (3) subjects were given an opioid during acute care; and (4) any measure of cerebral physiology was evaluated. Cerebral physiology measures were intracranial pressure (ICP), cerebral perfusion pressure (CPP), and mean arterial pressure (MAP). Subject and study characteristics, treatment protocol, and results were extracted from included studies. Randomized controlled trials were evaluated for methodological quality using the Physiotherapy Evidence Database tool. Levels of evidence were assigned using a modified Sackett scale.
In total, 22 studies met inclusion criteria, from which six different opioids were identified: morphine, fentanyl, sufentanil, remifentanil, alfentanil, and phenoperidine. The evidence for individual opioids demonstrated equally either: (1) no effect on ICP, CPP, or MAP; or (2) an increase in ICP with associated decreases in CPP and MAP. In general, opioids administered by infusion resulted in the former outcome, whereas those given in bolus form resulted in the latter. There were no significant differences when comparing different opioids, with the exception of one study that found fentanyl was associated with lower ICP and CPP than morphine and sufentanil. There were no consistent results when comparing opioids to other non-opioid medications.
Several studies have assessed the effect of opioids on cerebral physiology during the acute management of TBI, but there is considerable heterogeneity in terms of study methodology and findings. Opioids are beneficial in terms of analgesia and sedation, but bolus administration should be avoided to prevent additional or prolonged unfavourable alterations in cerebral physiology. Future studies should better elucidate the effects of different opioids as well as varying dosages in order to develop improved understanding as well as allow for tighter control of cerebral physiology.
CPP: Cerebral Perfusion Pressure, GCS: Glasgow Coma Scale, ICP: Intracranial Pressure, MAP: Mean Arterial Pressure, PEDro: Physiotherapy Evidence Database, RCT: Randomized Controlled Trial, TBI: Traumatic Brain Injury.
创伤性脑损伤(TBI)后,建议优化脑生理功能以促进患者获得更有利的预后。伴随的疼痛和躁动通常用镇静和镇痛药物治疗,如阿片类药物。然而,阿片类药物对脑生理某些方面的影响尚未完全明确。
对急性护理期间阿片类药物对TBI脑生理影响的证据进行系统评价。
在五个电子数据库中进行全面的文献检索,以查找截至2017年11月发表的英文文章。纳入标准为:(1)研究样本为TBI患者;(2)样本量≥3;(3)患者在急性护理期间接受阿片类药物治疗;(4)评估了任何脑生理指标。脑生理指标包括颅内压(ICP)、脑灌注压(CPP)和平均动脉压(MAP)。从纳入研究中提取受试者和研究特征、治疗方案及结果。使用物理治疗证据数据库工具对随机对照试验的方法学质量进行评估。使用改良的Sackett量表确定证据水平。
共有22项研究符合纳入标准,从中确定了六种不同的阿片类药物:吗啡、芬太尼、舒芬太尼、瑞芬太尼、阿芬太尼和苯哌利定。针对每种阿片类药物的证据均表明:(1)对ICP、CPP或MAP无影响;或(2)ICP升高,同时CPP和MAP降低。一般来说,静脉输注阿片类药物会产生前一种结果,而大剂量给药则会产生后一种结果。比较不同阿片类药物时,除一项研究发现芬太尼与比吗啡和舒芬太尼更低的ICP和CPP相关外,无显著差异。将阿片类药物与其他非阿片类药物进行比较时,结果并不一致。
多项研究评估了阿片类药物在TBI急性处理期间对脑生理的影响,但研究方法和结果存在相当大的异质性。阿片类药物在镇痛和镇静方面有益,但应避免大剂量给药,以防止脑生理出现额外或延长的不利改变。未来的研究应更好地阐明不同阿片类药物以及不同剂量的影响,以便更好地理解并更严格地控制脑生理功能。
CPP:脑灌注压,GCS:格拉斯哥昏迷量表,ICP:颅内压,MAP:平均动脉压,PEDro:物理治疗证据数据库,RCT:随机对照试验,TBI:创伤性脑损伤